Ram Shrivastava
Psychiatry · New York, NYNPI 1750622031
Payments from drug & device makers
What this record shows
That places this record below the midpoint for psychiatry clinicians in NY, where the typical reported total is $125.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,781,646in research payments, 2019–2025
Across 232 payments — averaging $7679.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.4M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$201K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$93K
- H. Lundbeck A S$78K
How this compares
$0 in reported general payments places this provider in the 15th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in New York
- Manish ZinzuvadiaNew York$1.3M
- Jianping ChenNew York$1.2M
- Ulla Kristina LaaksoNew York$890K
- Kerry SulkowiczNew York$435K
- Ralph AquilaNew York$143K
- Daniel KarlinNew York$101K
- David StraussNew York$95K
- Anissa Abi-DarghamNew York$94K
- Robin McGarryNew York$69K
- Nicole AllenNew York$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.